Skip to main content
Premium Trial:

Request an Annual Quote

ABI/MDS Sciex and Austria s Biocrates to Develop Metabolomics Methods, Consumables

NEW YORK, Feb. 28 (GenomeWeb News) - Applied Biosystems and MDS Sciex will work with Biocrates Lifes Sciences of Innsbruck, Austria, to develop methods and consumables for metabolomics, the companies said today.

 

Under the agreement, the ABI/MDS Sciex joint venture will provide Biocrates with its QStar LC-MS/MS and API 4,000 Q LC-MS/MS mass spectrometry systems. Biocrates will develop consumables and methods for sample preparation and metabolomics analysis, the partners said in a statement.

 

ABI will distribute any products resulting from the collaboration. Financial terms of the partnership were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.